- ASSOCIATE CLINICAL PROFESSOR | Psychiatry
- Alzheimer's Disease
- Hospital Affiliation
- The Mount Sinai Hospital
- Office 212-241-8157212-241-8157
As Director of the Neuropsychological Testing and Evaluation Center, she provides neuropsychological assessment for memory disorders and teaches, "Introduction to Neuropsychological Assessment in Psychiatry and Geriatric Psychiatry". Dr. Martin conducts and supervises neuropsychological assessments, in addition to teaching and lecturing on the topic of neuropsychological testing and memory and aging. Dr. Martin's research interests include healthy aging in the elderly, Alzheimer's disease and related dementias, and women's cognitive changes throughout the lifespan. She receives research support from Mount Sinai's ADRC (Alzheimer's Disease Research Center) and the ADCS Project (Alzheimer's Disease Cooperative Study Site). Currently, she is Co-Investigator for a study about the Therapeutic Effects of Exercise in Adults with Amnestic Mild Cognitive Impairment at the ADRC (GCO # in process) as well as Co-Investigator for A Phase 2 Multi Center, Randomized, Double Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients with Mild to Moderate Alzheimer’s Disease (GCO#91-208) and Co-Investigator for A Double Blind, Randomized, Placebo Controlled, Parallel Group Study to Simultaneously Qualify a Biomarker Algorithm for Prognosis of Risk of Developing Mild Cognitive Impairment due to Alzheimer’s Disease (MCI due to AD) and to Test the Safety and Efficacy of Pioglitazone (AD 4833SR 0.8mg QD) to Delay the Onset of MCI due to AD in Cognitively Normal Subjects (TOMM40) (GCO# 13-1688). She wass PI for a multi-center 4-year longitudinal study to evaluate home-based methods for Alzheimer's disease prevention research (GCO #91-208(13) and is the center neuropsychologist and co-investigator for a study of deep brain stimulation for treatment of obsessive compulsive disorder (GCO #09-1479) in the department of Psychiatry.
Financial & Billing Information
Please direct any detailed billing or financial inquires to the Mount Sinai Psychiatry billing customer service number at 212-659-8752.
- Adjustment Disorder
- Alzheimer's Disease
- Attention Deficit Hyperactivity Disorder And Attention Deficit Disorder
- Mild Cognitive Impairment
- Vascular Dementia
PHD, New York University
Mount Sinai Hospital
Mount Sinai Hospital
Memory and Aging, Neuropsychology of Alzheimer's disease and related Dementias
Kellner C, Martin J, Strain J, Spodek L, Creighton J. Resolution of Amnestic Effects of an Extended Course of Electroconvulsive Therapy. Journal of ECT 2011 September; 27(3): 251-255.
Martin J, Gorenstein M. Normal Cognitive Aging. In: Brocklehurst's Textbook of Geriatric and Clinical Gerontology, Seventh Edition . Philadelphia, PA, Elsevier; 2010. pp170-177.
Li C, Neugroschl j, Zhu C, Umpierre M, Martin J, Huang Q, Zeng X, Sano M. Mobility Marker Associated with Cognitive Impairment in Elderly Chinese Immigrants. International Psychogeriatric Association (IPA), Taipei, Taiwan, December 9-11, 2016 2016; Poster.
Li C, Neugroschl J, Umpierre M, Martin J, Huang Q, Zeng X, Cai D, Sano M. Recruiting U.S. Chinese Elders Into Clinical Research for Dementia: Modelling Efficient Minority Recruitment. Alzheimer Disease & Associated Disorder – An International Journal;.
Burdick K, Russo M, Martin J. In Mount Sinai Expert Guides: Psychiatry. In: Oxford, England, John Wiley & Sons;.
Martin J, Li C. Normal Cognitive Aging. In: Brocklehurst’s Textbook of Geriatric and Clinical Gerontology, Eighth Edition. Philadelphia, Elsevier, 2015;.
Mitsis EM, Bender HA, Kostakoglu L, Machac J, Martin J, Woehr JL, Sewell MC, Aloysi A, Goldstein MA, Li C, Sano M, Gandy S. . A consecutive case series experience with [18F] florbetapir PET imaging in an urban dementia center: Impact on quality of life, decision making, and disposition. Molecular Neurodegeneration 2014 February; 9(1).
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Martin did not report having any of the following types of financial relationships with industry during 2016 and/or 2017: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.